Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mereo BioPharma (MREO) Return on Invested Capital (2023 - 2024)

Mereo BioPharma (MREO) has disclosed Return on Invested Capital for 2 consecutive years, with 12.68% as the latest value for Q3 2024.

  • On a quarterly basis, Return on Invested Capital changed N/A to 12.68% in Q3 2024 year-over-year; TTM through Sep 2024 was 12.68%, a N/A change, with the full-year FY2021 number at 1.26%, changed N/A from a year prior.
  • Return on Invested Capital was 12.68% for Q3 2024 at Mereo BioPharma, down from 0.63% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.53% in Q4 2023 to a low of 12.68% in Q3 2024.